Document Detail


Efficacy of pharmacologic glucagon in acute experimental pancreatitis.
MedLine Citation:
PMID:  3970671     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Microcirculatory derangements in the pancreas associated with acute pancreatitis may contribute to a low-flow state and lead to pancreatic necrosis. This study investigated the effects of glucagon, a selective mesenteric arterial dilator, on pancreatic ischemia in canine bile-trypsin-induced pancreatitis (BTP). Measurements of cardiac Index (CI), total pancreatic blood flow (QP), pancreatic oxygen consumption (O2CP), and pancreatic arteriovenous shunt flow (QAVS) were obtained prior to and after inducing BTP. Bile-trypsin-induced pancreatitis was induced in 18 dogs. Nine received lactated Ringer's solution alone (LRPAN) at 6.5 mL/kg/hr, nine received lactated Ringer's solution plus continuous Intravenous (IV) glucagon hydrochloride (GLUPAN) at 1.0 micrograms/kg/min, and nine undergoing periportal dissection without BTP received IV glucagon (GLUCON). Following BTP, CI, QP, and O2CP decreased significantly and QAVS remained unchanged in crystalloid-treated animals (LRPAN). Glucagon administration (GLUPAN) transiently increased CI and QP but failed to improve O2CP and did not change QAVS. The decrease in O2CP observed after BTP in association with a constant QAVS suggests a metabolic block to oxygen uptake at the cellular level. Glucagon in pharmacologic doses does not reverse abnormalities in O2CP and is therefore of questionable physiologic benefit in the treatment of acute pancreatitis.
Authors:
F E Eckhauser; J A Knol; M G Inman; W E Strodel
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Archives of surgery (Chicago, Ill. : 1960)     Volume:  120     ISSN:  0004-0010     ISO Abbreviation:  Arch Surg     Publication Date:  1985 Mar 
Date Detail:
Created Date:  1985-03-21     Completed Date:  1985-03-21     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9716528     Medline TA:  Arch Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  355-60     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute Disease
Animals
Dogs
Female
Glucagon / pharmacology*,  therapeutic use
Hemodynamics / drug effects
Isotonic Solutions / pharmacology
Male
Microcirculation
Oxygen Consumption / drug effects
Pancreas / blood supply,  drug effects*,  physiopathology
Pancreatitis / drug therapy,  physiopathology*
Random Allocation
Regional Blood Flow / drug effects
Chemical
Reg. No./Substance:
0/Isotonic Solutions; 8022-63-7/Ringer's lactate; 9007-92-5/Glucagon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Knee arthrodesis for failed total knee arthroplasty.
Next Document:  Combined pancreatic duct and upper gastrointestinal and biliary tract drainage in chronic pancreatit...